Total Payments
$2,827
2024 Payments
$461.74
Companies
31
Transactions
101
Medicare Patients
626
Medicare Billing
$67,287
Payment Breakdown by Category
Food & Beverage$1,703 (60.2%)
Consulting$1,100 (38.9%)
Education$23.89 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,703 | 98 | 60.2% |
| Consulting Fee | $1,100 | 1 | 38.9% |
| Education | $23.89 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,134 | 5 | $0 (2017) |
| Janssen Biotech, Inc. | $340.03 | 23 | $0 (2024) |
| Galvanize Therapeutics, Inc | $289.69 | 2 | $0 (2024) |
| Genentech USA, Inc. | $147.99 | 15 | $0 (2019) |
| Merck Sharp & Dohme LLC | $123.22 | 7 | $0 (2024) |
| Adaptive Biotechnologies Corporation | $82.48 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $79.15 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $57.23 | 4 | $0 (2018) |
| Gilead Sciences Inc | $55.86 | 4 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $51.39 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $461.74 | 9 | Galvanize Therapeutics, Inc ($289.69) |
| 2023 | $103.48 | 3 | Adaptive Biotechnologies Corporation ($82.48) |
| 2022 | $42.27 | 2 | Janssen Biotech, Inc. ($42.27) |
| 2020 | $19.63 | 1 | Janssen Pharmaceuticals, Inc ($19.63) |
| 2019 | $62.27 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($24.28) |
| 2018 | $99.29 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($54.87) |
| 2017 | $2,038 | 76 | PFIZER INC. ($1,134) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Galvanize Therapeutics, Inc | ALIYA SYSTEM (Device) | Food and Beverage | In-kind items and services | $248.91 | General |
| Category: PULSED ELECTRIC FIELD | ||||||
| 11/22/2024 | Galvanize Therapeutics, Inc | ALIYA SYSTEM (Device) | Food and Beverage | In-kind items and services | $40.78 | General |
| Category: PULSED ELECTRIC FIELD | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Oncology | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Oncology | ||||||
| 05/21/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Oncology | ||||||
| 02/07/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Oncology | ||||||
| 10/18/2023 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $39.45 | General |
| Category: ONCOLOGY | ||||||
| 05/24/2023 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $43.03 | General |
| Category: ONCOLOGY | ||||||
| 03/13/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 03/10/2022 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Oncology | ||||||
| 03/01/2022 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Oncology | ||||||
| 10/28/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/29/2019 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Oncology | ||||||
| 04/11/2019 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Oncology | ||||||
| 03/27/2019 | Genentech USA, Inc. | GAZYVA (Biological) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: BioOncology | ||||||
| 03/13/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.39 | General |
| Category: Oncology | ||||||
| 12/13/2018 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $19.53 | General |
| 12/04/2018 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2018 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $13.98 | General |
| 03/29/2018 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Oncology | ||||||
| 03/21/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Oncology | ||||||
| 02/27/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 62 | 109 | $17,654 | $6,636 |
| 2022 | 3 | 138 | 260 | $41,943 | $17,141 |
| 2021 | 4 | 170 | 324 | $49,380 | $21,353 |
| 2020 | 7 | 256 | 469 | $59,481 | $22,157 |
Total Patients
626
Total Services
1,162
Medicare Billing
$67,287
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 59 | $10,245 | $4,159 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 40 | 50 | $7,409 | $2,477 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 33 | 109 | $17,799 | $8,067 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 76 | 122 | $16,961 | $6,080 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 29 | 29 | $7,183 | $2,994 | 41.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 48 | 148 | $22,846 | $11,293 | 49.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 79 | 133 | $17,434 | $6,579 | 37.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 16 | 16 | $3,799 | $1,743 | 45.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 27 | 27 | $5,301 | $1,738 | 32.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 93 | 207 | $26,496 | $8,168 | 30.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 51 | 114 | $17,100 | $7,138 | 41.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 28 | $2,832 | $1,628 | 57.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 23 | $3,450 | $1,367 | 39.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 15 | 16 | $2,800 | $1,306 | 46.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 23 | $2,944 | $994.37 | 33.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 13 | 13 | $2,470 | $725.25 | 29.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 15 | 17 | $935.00 | $535.94 | 57.3% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Facility | 2020 | 16 | 28 | $453.32 | $293.93 | 64.8% |
About Naheed Alam
Naheed Alam is a Hematology & Oncology healthcare provider based in Dunkirk, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1255592168.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Naheed Alam has received a total of $2,827 in payments from pharmaceutical and medical device companies, with $461.74 received in 2024. These payments were reported across 101 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($1,703).
As a Medicare-enrolled provider, Alam has provided services to 626 Medicare beneficiaries, totaling 1,162 services with total Medicare billing of $67,287. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Dunkirk, NY
- Active Since 06/23/2008
- Last Updated 03/17/2018
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1255592168
Products in Payments
- ALIYA SYSTEM (Device) $289.69
- DARZALEX (Biological) $162.46
- IMBRUVICA (Drug) $121.79
- KEYTRUDA (Biological) $101.05
- clonoSEQ (Device) $82.48
- NINLARO (Drug) $72.37
- Perjeta (Biological) $45.21
- Neulasta (Biological) $44.19
- ERLEADA (Drug) $42.27
- GILOTRIF (Drug) $39.47
- Xofigo (Drug) $39.35
- GAZYVA (Biological) $37.99
- XARELTO (Drug) $34.42
- TAGRISSO (Drug) $33.61
- KISQALI (Drug) $31.63
- Imbruvica (Drug) $30.61
- OPDIVO (Biological) $28.99
- Herceptin (Biological) $24.79
- Lenvima (Drug) $22.22
- KRAZATI (Drug) $21.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.